发明授权
- 专利标题: ULBP antibodies
- 专利标题(中): ULBP抗体
-
申请号: US12221490申请日: 2008-08-04
-
公开(公告)号: US07807796B2公开(公告)日: 2010-10-05
- 发明人: David J Cosman , Jurgen Mullberg , William C Fanslow, III , Marek Z Kubin , Richard J Armitage
- 申请人: David J Cosman , Jurgen Mullberg , William C Fanslow, III , Marek Z Kubin , Richard J Armitage
- 申请人地址: US CA Thousand Oaks
- 专利权人: Immunex Corporation
- 当前专利权人: Immunex Corporation
- 当前专利权人地址: US CA Thousand Oaks
- 代理商 Susan E. Lingenfelter
- 主分类号: C07K16/18
- IPC分类号: C07K16/18 ; C12P21/08
摘要:
The invention is directed to purified and isolated novel ULBP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above. ULBP polypeptide can be found on the surface of human B cell lymphomas. Mammalian forms of ULBP polypeptide in isolated or purified forms are provided. In addition, isolated nucleic acids encoding ULBP polypeptides and expression vectors comprising a cDNA encoding ULBP polypeptides are provided. The ULBP polypeptides can be isolated or synthesized and used to prepare antibodies, and in particular monoclonal antibodies, against the polypeptides. The antibodies, in turn, are useful for detecting the presence of ULBP polypeptides in human cell samples, which can be correlated with the existence of a malignant condition in a patient. ULBP polypeptides stimulate IFN-γ production, NK cell proliferation, and CTL activity.
公开/授权文献
- US20090324597A1 ULBP antibodies 公开/授权日:2009-12-31
信息查询